When patients ask about weight changes with antidepressants, providing guidance can be challenging. While bupropion is often considered weight-neutral and paroxetine an offender, how do other common antidepressants compare?

Learn about the risks and efficacy of gepirone (Exxua) for treating MDD.

Patients with atypical parkinsonism are less responsive to levodopa, and psychiatric medications can exacerbate motor symptoms. Dr. Flaherty advises how to choose the right treatment in patients with parkinsonism accompanied by psychosis, apathy, anxiety, and depression.

A brief review of hyponatremia including medications that cause it, symptoms to look out for, and how to prevent and treat this common side effect.

Benzodiazepines are highly beneficial for managing anxiety and agitation in psychiatric inpatient settings, but we must be cautious about prescribing them to patients with substance use disorders (SUDs). Here we review strategies to reduce the risk of benzodiazepine misuse and discuss alternative medication options, including second-generation antipsychotics, antidepressants, gabapentin, and pregabalin.

A large analysis raises questions about antidepressant efficacy in certain age groups, and also finds a sweet spot.

New research calls to question the common practice of antidepressant combinations. Dr. Posternak makes sense of it.